Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (meloxicam) used to prevent episodes of arthritis in patients with gout during initiation of allopurinol therapy. The study has demonstrated that one-month therapy with Amelotex®...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/383 |
| _version_ | 1826556965625528320 |
|---|---|
| author | M S Eliseyev S A Vladimirov |
| author_facet | M S Eliseyev S A Vladimirov |
| author_sort | M S Eliseyev |
| collection | DOAJ |
| description | The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (meloxicam) used to prevent episodes of arthritis in patients with gout during initiation of allopurinol therapy. The study has demonstrated that one-month therapy with Amelotex® can minimize the risk of arthritis exacerbations when allopurinol is used. Amelotex® shows a good tolerability and causes the low rates of side effects |
| first_indexed | 2024-04-10T02:08:37Z |
| format | Article |
| id | doaj.art-348964309f524c878e62db52224c8c10 |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2025-03-14T08:21:05Z |
| publishDate | 2011-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-348964309f524c878e62db52224c8c102025-03-02T13:10:55ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2011-12-0154495210.14412/1996-7012-2011-6981688Use of meloxicam (Amelotex®) in patients with chronic gout to preventM S EliseyevS A VladimirovThe paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (meloxicam) used to prevent episodes of arthritis in patients with gout during initiation of allopurinol therapy. The study has demonstrated that one-month therapy with Amelotex® can minimize the risk of arthritis exacerbations when allopurinol is used. Amelotex® shows a good tolerability and causes the low rates of side effectshttps://mrj.ima-press.net/mrj/article/view/383goutmeloxicamallopurinol |
| spellingShingle | M S Eliseyev S A Vladimirov Use of meloxicam (Amelotex®) in patients with chronic gout to prevent Современная ревматология gout meloxicam allopurinol |
| title | Use of meloxicam (Amelotex®) in patients with chronic gout to prevent |
| title_full | Use of meloxicam (Amelotex®) in patients with chronic gout to prevent |
| title_fullStr | Use of meloxicam (Amelotex®) in patients with chronic gout to prevent |
| title_full_unstemmed | Use of meloxicam (Amelotex®) in patients with chronic gout to prevent |
| title_short | Use of meloxicam (Amelotex®) in patients with chronic gout to prevent |
| title_sort | use of meloxicam amelotex r in patients with chronic gout to prevent |
| topic | gout meloxicam allopurinol |
| url | https://mrj.ima-press.net/mrj/article/view/383 |
| work_keys_str_mv | AT mseliseyev useofmeloxicamamelotexinpatientswithchronicgouttoprevent AT savladimirov useofmeloxicamamelotexinpatientswithchronicgouttoprevent |